Guidance
Update information
August 2017: We reviewed the evidence and updated recommendations in section 1.1 on assessing oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status on disease recurrence.
July 2014: We reviewed the evidence on exercise for people with or at risk of lymphoedema and added 2 recommendations to section 1.5.
Recommendations are marked as [2017], [2014] or [2009].
[2017] indicates that the evidence was reviewed and the recommendation updated in 2017.
[2014] indicates that the evidence was reviewed and the recommendation added in 2014.
[2009] indicates that the evidence was reviewed in 2009.
Minor changes since publication
January 2022: Minor changes to redirect NICE Pathways links.
ISBN: 978-1-4731-0631-4